White label ELPA - ClinicalTrials.eu

Study of tacrolimus, everolimus and mycophenolate mofetil combination in elderly patients after kidney transplant

Not recruiting

3 1 1 1
Investigated diseases:
- Renal transplant
Investigated drugs:
Study on WT1/IL15/IL15Ra mRNA DC Vaccine for Patients with Advanced or Refractory Solid Tumors of the Pancreas, Esophagus, Liver, or Ovaries

Not recruiting

2 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Wt1/Il15/Il15Ra Mrna Dc
A Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- Cabazitaxel
Study of WT1 LAMP mRNA DC Vaccine for Patients with Malignant Pleural Mesothelioma

Not recruiting

2 1 1
Investigated diseases:
- Pleural mesothelioma malignant
Investigated drugs:
- Wt1 Lamp Mrna Dc
Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Triple negative breast cancer
Investigated drugs:
+4
Study on Semaglutide for Preventing Metabolic Issues in Prediabetic or Diabetic Patients with Schizophrenia on Clozapine or Olanzapine

Not recruiting

2 1 1
Investigated drugs:
- Semaglutide
Study of Erlotinib and LY2875358 for Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Mutations After Initial Erlotinib Treatment

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Emibetuzumab
- Erlotinib
Trial of Ataluren for Severe Common Variable Immunodeficiency with Autoimmunity in Patients with LRBA Deficiency

Not recruiting

2 1 1 1
Investigated drugs:
- Ataluren
Study on the Safety and Effectiveness of GB1211 and Atezolizumab for Patients with Non-Small Cell Lung Cancer

Not recruiting

1 1 1
Investigated diseases:
- Non-small cell lung cancer stage IIIB
- Non-small cell lung cancer stage IV
Investigated drugs:
- 5-Bromopyridin-3-Yl 3-Deoxy-1-Thio-3-[4-(3,4,5-Trifluorophenyl)-1H-1,2,3-Triazol-1-Yl]-Alfa-D-Galactopyranoside
- Atezolizumab
Comparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies